您的位置: 首页 > 农业专利 > 详情页

NOVEL INFLUENZA VIRUS
专利权人:
NANOTHERAPEUTICS; INC.
发明人:
Thomas Muster,Ekaterina Romanovskaya-Romanko,Oleg Kiselev,Markus Wolschek,Boris Ferko,Andrej Egorov
申请号:
US15655306
公开号:
US20180016560A1
申请日:
2017.07.20
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention provides a novel influenza virus wherein both the NS and the PB1 gene segments are modified and wherein the PB1-F2 open reading frame is modified by introduction of at least one stop codon. Specifically, the influenza virus is lacking functional NS1 and PB1-F2 proteins. Additionally, a vaccine formulation comprising said modified influenza virus is provided and its use for prevention of influenza infection.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充